AI Article Synopsis
- The study evaluated the safety of Sanyak (Dioscoreae rhizoma) pharmacopuncture in healthy participants.
- Pain after injection was notably significant in those who received the alcohol extract of Sanyak.
- Despite some changes in blood tests and liver function metrics post-injection, all results remained within normal limits, suggesting that Sanyak pharmacopuncture is safe with no severe adverse effects.
Article Abstract
The study was conducted to evaluate the safety of Sanyak (Dioscoreae rhizoma) pharmacopuncture by injecting to healthy participants. Among the subjective symptoms, pain after the injection was statistically significant in the group injected with alcohol extract of Sanyak. The mean platelet volume and blood in the urinalysis after the injections were statistically significant between groups. After injections, the total protein level in liver function tests and hematocrit changed significantly. However, all of these changes were within normal limits, and Sanyak pharmacopuncture did not cause any severe physical responses or subjective symptoms and may, therefore, be considered safe.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jams.2012.12.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of Dioscoreae Rhizoma (SanYak) on Peripheral Neuropathy and its Safety.
J Pharmacopuncture
September 2013
Department of Acupuncture & Moxibustion, Oriental Hospital of Daejeon University, Daejeon, Korea.
Objectives: This study aimed to evaluate the evidence available in the literature for the safety and efficacy of Dioscoreae Rhizoma(DR) for the treatment of peripheral neuropathy.
Methods: Literature searches were performed in MEDLINE and three Korean medical databases up to April 2013. All studies evaluating the effects on peripheral neuropathy or the safety of DR monopreparations were considered.
Evaluation of the safety of Sanyak (Dioscoreae rhizoma) pharmacopuncture according to the extraction method: a double-blind randomized controlled trial.
J Acupunct Meridian Stud
February 2013
Department of Oriental Medicine, Daejeon University, Daejeon, Republic of Korea.
Article Synopsis
- The study evaluated the safety of Sanyak (Dioscoreae rhizoma) pharmacopuncture in healthy participants.
- Pain after injection was notably significant in those who received the alcohol extract of Sanyak.
- Despite some changes in blood tests and liver function metrics post-injection, all results remained within normal limits, suggesting that Sanyak pharmacopuncture is safe with no severe adverse effects.
Clinical research of the efficacy and the safety of dioscoreae rhizoma (sanyak) pharmacopuncture therapy for peripheral facial paralysis patients.
J Pharmacopuncture
December 2012
Department of Acupuncture & Moxibustion, Oriental Hospital of Daejeon University, Daejeon, Korea.
Objectives: The aim of this study is to evaluate the efficacy and the safety of Sanyak pharmacopuncture therapy for the treatment of peripheral facial paralysis patients.
Methods: This study was a retrospective investigation of a total of 70 patients who were inpatients of the Oriental Hospital of Daejeon University between January 1, 2011, and May 31, 2012, and who were diagnosed as having peripheral facial paralysis by physical examination, the patients received three different interventions. Eleven (11) patients were treated with acupuncture and alcohol Dioscorea rhizoma pharmacopuncture (ADG), 25 patients with acupuncture and distillation Dioscorea rhizoma pharmacopuncture (DDG), and 34 patients with acupuncture and non-Dioscorea rhizoma pharmacopuncture (NDG).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!